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S U M M A R Y  
The knowledge of the three-dimensional (3D) structures and conformational dynamics of proteins and 
peptides is important for the understanding of biochemical and genetic data derived for these molecules. This 
understanding can ultimately be of help in drug design. We describe here the role of Nuclear Magnetic 
Resonance (NMR) spectroscopy in this process for three distinct situations: for small proteins, where 
relatively simple NMR methods can be used for fhll 3D structure determination; for larger proteins that 
require multinuclear multidimensional NMR but for which full 3D structures can still be obtained; and for 
small peptides that are studied in interaction with macromolecules (receptors) using specialized NMR 
techniques. A fourth situation, pertaining to large systems where only partial structural information can be 
obtained from NMR data, is briefly discussed. Molecules of interest to the biomedical field (C5a and 
stromelysin) are discussed as examples. 
I N T R O D U C T I O N  
The importance of  nuclear magnetic resonance (NMR) spectroscopy for drug design arises 
from the fact that this technique has become a major tool for the determination of  conformations 
of  biological molecules in solution. Once conformations of (bound) drugs, their target molecules 
or their complexes are known, molecular design processes can take place to help improve many 
aspects of  the quality of the drug. Here we will focus on the impact of  N M R  spectroscopy on the 
determination of  protein and peptide conformations in solution and how the information obtained 
can affect the design process. It is quite customary to try to compare the conformational informa- 
tion obtained from N M R  with that obtained from X-ray crystallography. We will not go into 
these questions, except that we will discuss an intriguing difference in crystal and solution struc- 
tures of  the anaphylatoxin C3a. Instead, let us ask what distinguishes N M R  from other spectro- 
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scopic techniques such as UV/VIS, infrared or M6ssbauer. Why can one determine 3D structures 
of proteins with NMR but not with other spectroscopic methods? It is certainly not the basic 
physics: in NMR, as well as in other spectroscopies, transitions between energy levels are induced 
by matching the frequency of a photon between them (the transitions are called resonances in 
NMR); the fact that an external magnet is needed to create the difference in energy levels for 
NMR is not really relevant. As in other spectroscopies, the excited NMR states relax back to their 
ground state with some characteristic lifetime. What distinguishes NMR from most other spec- 
troscopies is the timescale of such lifetimes. NMR relaxation times can be seconds in contrast to 
the characteristic nano- and picoseconds in optical spectroscopies, owing to the fact that the 
nuclei involved in NMR are physically very isolated from each other. The slow relaxation (long 
lifetime) of nonequilibrium states of the nuclear spin energy levels allows application of coherent 
spectroscopy. This means that it is technically feasible to pump a second photon (or many more) 
into the system after initial excitation, before it can relax back to its ground state. Thus, multiple- 
quantum excitations can be generated with relative ease in NMR. Transition energies can be 
passed between nuclei on resonant terms. The long lifetimes also enable application of NMR in 
many frequency dimensions, which in turn makes it possible to assign the resonances in the NMR 
spectrum to individual nuclei in the molecule under study. Energy transfers between many 
assigned resonances can then be studied. The efficiencies of these energy transfers are dependent 
on the structure and conformation of the molecule. In particular, the important energy transfer 
mechanism called the Nuclear Overhauser Effect (NOE) is only effective when nuclei are separat- 
ed by no more than 5 A in space. Thus, when an NOE can be measured between two resonances, 
it means that the pair of nuclei associated with these resonances are close in space. When a dense 
network of these NOEs between assigned resonances can be measured, the distance information 
can be transformed into a molecular model, generally using computational methods. Depending 
on the characteristics of the molecule under study and the conditions of the experiment, 3D 
structures can be determined with atomic precision for molecules up to at least 20 and possibly 30 
kDa. An important feature is that these high-resolution NMR structures are (and have to be) 
determined in solution, where in most cases conditions can be chosen similar to native ones. 
In order to give the general reader the opportunity to appreciate the possibilities and limita- 
tions of the modem NMR methods (which are often referred to as two-, three-, four- or multidi- 
mensional NMR, heteronuclear, multinuclear NMR, triple- and quadruple-resonance NMR, 
isotope-edited, isotope-directed NMR and all combinations thereof), we include a very basic 
NMR tutorial in the next section. A major part of this contribution consists of a description of an 
NMR study of the small inflammatory protein C5a and the impact of the obtained information 
on drug design. The following section illustrates the initial stages of an NMR study of the much 
larger human stromelysin for which the new multinuctear multidimensional NMR methods have 
to be used. The last section will describe how these methods come together in the study of smaller 
ligands in interaction with larger structures. 
SOME NMR BASICS 
NOE 
A very important energy transfer mechanism is the Nuclear Overhauser Effect [1]. It is mediat- 
ed by the through-space magnetic interaction between the nuclear magnets themselves. When the 
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molecule tumbtes through solution, the interaction between these magnets, represented by ordi- 
nary dipoles, becomes modulated because it is dependent on their relative orientations. The 
radio-frequency electromagnetic fields generated by the time-modulated magnetic interaction will 
cause magnetic resonance. This 'internal' magnetic resonance will even out (relax) the nonequili- 
brium magnetic states initially generated by the NMR experiment. The rates of relaxation are 
inversely proportional to r 6, where rij is the distance between nuclei i and j in an NOE pair. Careful 
measurement of these rates (NOE build-up rates) yields distance information in the range 2~5 A, 
with a precision of a few tenths of an Angstrom. 
Two-dimensional NMR 
NMR energies are small compared to thermal energies and the nuclear energy levels will be 
nearly equally populated at equilibrium. The small difference that does exist gives rise to a net 
macroscopic magnetic moment. At equilibrium, the magnetic moment is perfectly aligned with 
the magnetic field. NMR experiments are carried out by delivering radio-frequency (r.f.) pulses 
to the sample. This is equivalent to whipping a spinning top; the top will start to precess around 
the vertical axis. Analogously, the magnetic moment will precess around the direction of the 
external magnetic field. This precession gives rise to an oscillating electromagnetic field (Free 
Induction Decay or FID) that can be picked up by a wire coil antenna. The frequency of the FID 
is equal to the frequency of the NMR transition excited in the first place. When different nuclei 
are excited in the sample, the time-domain signal will be a superimposition of all the individual 
transitions with different frequencies. Fourier transformation of this composite FID gives the 
frequency spectrum (see row 1 of Fig. 1). In the 2D NMR experiment one does not wait until the 
FID has died out; because of the slow relaxation back to equilibrium as described above, one has 
time to issue a second pulse on the nonequilibrium state. The effect of this second puIse will 
depend on the moment it is delivered; just like the outcome of a second whiplash on the top's 
precession will depend on the position of the top when it is hit. Let us assume for simplicity that 
the second r.f. pulse does nothing but select for the amplitude of the signal as indicated in Fig. 1. 
If we record the effect of this second pulse as a function of the delay between the two pulses (this 
time is denoted tl), we obtain FIDs (denoted t2) that are amplitude-modulated as a function of tl. 
Fourier transformation of this series of FIDs gives rise to a series of amplitude-modulated 
spectra. The frequency of this amplitude modulation is of course given by the frequency present 
during tl; this frequency can be measured by carrying out a second Fourier transformation over 
corresponding points of the amplitude-modulated spectra in the orthogonal direction [2]. The 
obtained 2D frequency-domain spectrum (fl,fz), which is generally represented as a contour 
diagram, is not very interesting when the frequencies in t~ and t2 a re  the same: the 2D spectrum 
is a diagonal as shown in Fig. 1. The 2D spectrum becomes informative when the frequencies in 
t~ and t2 are not equal. This can be invoked when, instead of a single pulse, a rest period flanked 
by two pulses is inserted in the experiment. During this rest time the NOE energy transfer 
becomes active. A customary description of the processes involved is that resonance energy 
residing on nucleus A with frequency FA during tl is transferred to the spatially close nucleus B 
in the rest period. After the rest it will be measured with an FID (tz) of frequency FB. The 2D 
spectrum is now a correlation diagram: the off-diagonal peak at coordinates (FA,FB) correlates 
the two nuclei A and B, in this example by NOE. As a real example, consider the 2D NOE 
spectrum of C5a, a 75-amino acid protein of the complement system (Fig. 3). The off-diagonal 
394 




> tl > fl 
Fig. 1. Schematic representation of the recording and processing of a 2D NMR spectrum. Left top: the squares represent 
the r.f. pulses that demarcate the two time periods t t and t 2. The squiggly ]ins are the FIDs; note that they are amp]Rude 
modulated as a function of t 1. Right top: the result after Fourier transformation of this series of £IDs. The frequency- 
domain spectra (fz) are amplitude modulated as a function of q. Left bottom: a transposed representation of the same 
data. Corresponding points in f2 give rise to t~ 'FIDs'. Right bottom: the final result of the 2D Fourier transformation: 
a peak is found on the diagonal. 
peaks give the distance correlations between the nuclei in the sample. If the assignments of the 
resonances are known, these correlations can be interpreted in structural terms. 
Coherence transfer through scalar couplings 
The NOE is not the only energy-transfer process between transitions. The second, and equally 
important process is known as coherence transfer through scalar couplings or just as coherence 
transfer [2]. The scalar coupling is an interaction between nuclear spins, mediated by electrons in 
the chemical bonds joining the nuclei. By this process, nucleus A senses the state of nucleus B. 
Scalar couplings occur in principle between all magnetic nuclei in a molecule; however, the effect 
becomes unmeasurably small if more than three or four chemical bonds separate the nuclei. When 
three or four intervening bonds are involved in the mediation of the interaction, the scalar 
coupling depends on the dihedral angle described by the chemical bonds and becomes a confor- 
mational marker by itself. The dihedral angles obtained from measurement of the couplings are 
used as additional input for structure-determination algorithms. 
It is impossible to describe the energy transfer by scalar coupling from one transition to the 
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other in terms other than quantum mechanics. In very general terms, however, one can state that 
when the energy levels of nucleus A are affected by the nuclear state of the scalarly coupled 
nucleus B, transitions of B (which affect the nuclear state of B) are sensed by transitions of A. 
Thus, transfer of transition 'information' between nuclei is possible via the scalar coupling. The 
first 2D experiment called COSY (for correlation spectroscopy - -  a much too generic name) just 
transfers coherence from one nucleus to the other over the scalar couplings [2]. When executed as 
a 2D experiment, cross peaks will thus indicate that the corresponding nuclei are part of the same 
molecule and separated by not more than three (or sometimes four) chemical bonds. The COSY- 
style experiments thus delineate the chemical structure of a component, whereas NOESY-style 
experiments characterize the conformation of the molecule. 
Multidimensional NMR 
The principle of 2D NMR is easily extended to three or more dimensions. First, we need 
mechanisms to transfer information between nuclei. For example, let information from the 
resonance associated with nucleus A be carried to nucleus B by NOE and from nucleus B to 
nucleus C by scalar coupling. If we now record the FID of C as a function of the time the 
magnetization resided on A and as a function of the time it resided on B, we obtain a 3D 
time-domain matrix. Fourier transformation of this 3D experiment will give 3D cross peaks in a 
frequency-domain spectrum. The existence of the cross peak will show that A is spatially close to 
B, which is in turn within three chemical bonds of C. The three frequency axes of the cross peak 
determine the frequencies of A, B and C, respectively. Practical examples of 3D experiments will 
be discussed in conjunction with the NMR studies of stromelysin. 
A 3D experiment can still be depicted in our minds, but we have problems if dimensionality 
goes beyond that. However, molecules, quantum mechanics, NMR instrument and computers 
easily cope. Take a (not so hypothetical) 5D experiment in which magnetization information is 
passed by heteronuclear scalar couplings in a labeled peptide from H~(i) to C~(i) to CO(i) to 
N(i + 1) to H•(i + 1). Occurrence of cross peaks in the 5D matrix would indicate that the named 
nuclei are connected in the molecular framework. The five dimensions would give the five fre- 
quencies of the connected nuclei. If the assignment for one of them is known, this experiment 
would give the assignment for the other four. The number of achievable dimensions is practically 
limited by relaxation, sensitivity and resolution. For most larger molecules where multidimen- 
sional NMR is necessary for data analysis, the limit lies currently around four dimensions. 
THREE-DIMENSIONAL STRUCTURE DETERMINATION OF C5a AND IDENTIFI- 
CATION OF THE C5a-RECEPTOR INTERACTION 
Background 
C5a is the N-terminal 74-amino acid fragment of the C5 complement protein, released upon 
cleavage by C3b. C5a is a primary mediator of inflammation and recruits leukocytes to the site of 
complement activation. Pathologic complement activation occurs in auto-immune diseases such 
as arthritis and asthma, resulting in tissue damage inflicted by the recruited lymphocytes (for a 
review, see Reference 3). It is therefore thought that a compound that competes with the binding 
of C5a to its leukocyte receptor in an antagonistic way may be a useful therapeutical against some 
of the symptoms of the mentioned diseases. The basic idea is to develop a low-molecular-weight 
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compound that mimics the receptor-interface site of C5a on the basis of the 3D structure of that 
site. No 3D structure was known for C5a; a 3.5/k resolution crystal gtructure was known for the 
highly homologous C3a [4]; the receptor for C5a was unavailable. The approach was (i) to 
determine the 3D structure of C5a by NMR in solution; (ii) to use mutagenesis to identify residues 
that are involved in the C5a receptor binding; and (iii) to combine (i) and (ii) in a 3D template to 
be used for rational drug design. 
N M R  structure determination 
With 75 amino acids, C5a is sufficiently small to be amenable to 2D proton NMR. The upper 
limit for such approaches lies around 10 kDa; above this molecular weight the relaxation process- 
es become too fast to allow the through-bond proton COSY-type experiments which are crucial 
for 2D NMR data analysis [5]. For C5a, we used such experiments to correlate the resonances 
within the spin systems of amino acids. Most amino acids give rise to unique connectivity patterns 
in these experiments and could thus be recognized by type. The identified amino acid residues 
were placed in the primary structure with the aid of a NOESY experiment. We made use of the 
property that at least one of the distances d~N(i,i + 1) or dNN(i,i + 1) between the alpha and 
amide protons (N) or between amide protons of sequential residues i and i + 1 is smaller than 3 
and thus within range of NOE energy transfer [5]. Thus connections between the protons of 
sequentially adjacent residues were made, leading to the so-called sequence-specific assign- 
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Fig. 2. Secondary structure determination of  C5a in solution. Lines in lane a represent the presence of  a strong cross peak 
dc~N(i,i + 1) in the NOESY spectrum (indicative of  extended structure) for the indicated residues. Lines that  connect 
residues in lane b point  to the presence o f  a s t rong cross peak dNN(i,i  _+ t) (indicative of  helical structure) in the NOESY 
spectrum. Lines in lane c represent strong cross peaks dc~N(i,i + 3) and dc~N(i,i + 4) and lines in lane d indicate dcq~(i,i + 3) 
(all indicative of  helical structure). Lane e identifies amide protons protected from exchange with the solvent. 
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ment [6]. Figure 2 shows the obtained connections for C5a. It is immediately apparent that many 
strong dNN NOEs were observed for this protein• Of course, this means that the corresponding 
distances in the protein are small; this is indicative of the presence of helices, where dNN is 2.8 A. 
In extended structures the distance is 4.8 A and generally beyond detection possibility by NOE. 
The d~N(i,i + 1) distance in helical regions is relatively long (3.5/k) and thus gives rise to weaker 
NOEs in these areas. Once there are indications that a protein is hetical, one undertakes a grid 
search for so-called medium-range connectivities that corroborate the identification of secondary 
structure [7]: the o~-helical pitch of 3.6 residues per turn brings the H a of residue i in close 
proximity to the H N of residues i + 3 (3.5 A) and i + 4 (4.2 A). The corresponding NOEs, termed 
do~N(i,i + 3) and dtxN(i,i + 4), are shown in Fig. 2, together with an NOE corresponding to 
another small distance in a helix (do~[3(i,i + 3)). The locations of four a-helices are clearly outlined 
by these NOEs. In order to further characterize the secondary structure, the solvent exchange 
rates of  the labile amide protons were determined. Amide protons exchanging slowly are protect- 
ed from solvent by hydrogen bonding, protein bulk or both [8]. In the case of small proteins such 
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Fig. 4. Stereodiagram of the 3D structure of C5a in solution as determined from NMR data, represented as an ensemble 
of 11 structures using dashed lines (C a atoms only). The 3D structure of C3a in the crystal as determined from X-ray 
diffraction data is shown as a bold line. 
as C5a, hydrogen bonding is the most likely cause of  exchange protection. The slowly exchanging 
protons are indicated in Fig. 2 and align perfectly with the helical stretches. In parallel and 
antiparallel 13-sheets, d a N  distances are very short (2.2/~), giving rise to very strong NOE cross 
peaks and dNN distances too long for appreciable NOEs. It is clear that C5a does not  contain 
such stretches of  sheet. For  the C-terminal 10 residues one observes fairly strong d a N  and dNN 
NOEs simultaneously and also some medium-range connectivities. These NOEs indicate that this 
area does not conform to a standard secondary structure where these NOEs are mutually exclu- 
sive; rather, the molecule is here in dynamic equilibrium between many states. This is corroborat- 
ed by the fact that amide protons exchange fast in this region, showing that no stable hydrogen- 
bonding pattern is formed. Relaxation measurements revealed that the mobility of  the C-terminal 
part of  C5a becomes monotonically larger when proceeding from Ala 63 towards the end of the 
molecule; the last four residues move ten times as fast in solution as the core of the protein and 
behave as if they were part of a small peptide [9]. It is difficult to state the nature of  the dynamic 
equilibrium; because of the r -6 distance dependence of  NOEs, close distances are strongly over- 
emphasized in the average NOE. Thus, even when the majority of  time is spent as random 
extended structure and only a small fraction of  time in a helical conformation, dNN NOEs would 
accumulate. (This nongeometric averaging of  NOE is utilized in transferred NOE experiments 
discussed below.) 
The results of  this investigation thus reveal that C5a consists of  four a-helices and that the 
molecule has a partially disordered C-terminal decapeptide. In order to proceed with 3D structure 
determination [10], the NOE data were further searched for NOEs between protons that are 
remote in sequence, but still within 4/~. For  an a-helical protein, most of  these so-called long- 
range NOEs are found between side-chain resonances and thus occur in a relatively crowded part 
of the NOESY spectrum (see Fig. 3). The NOEs were interpreted with extreme care: only NOEs 
that could be observed at a very short mixing time (50 ms) were included in the calculation. The 
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3D structure of C5a was determined using these long-range NOEs and the data determining the 
secondary structure (no hydrogen bonds in the first rounds). As no NOEs were identified posi- 
tioning the C-terminal 11 residues of the molecule (corroborating its random structure), structure 
calculations were carried out for the fragment containing residues 1-63 only. The structure of C5a 
was computed from the NMR data with a dihedral-angle-driven distance geometry (DG) pro- 
gram [11,12] and 5 ps of restrained molecular dynamics (MD) [13-15]. The final ensemble of 11 
structures [10] was compatible with the observed presences and absences of NOEs and with well- 
established model potential-energy functions. The ensemble is shown in Fig. 4, together with the 
crystal structure of C3a. 
Structure evaluation, mutagenesis and receptor interaction 
Comparison of the solution structure of C5a [10] with the crystal structure of C3a [4] (Fig. 4) 
reveals correspondences as well as some striking differences. The second and third helices (see 
Fig. 2) as well as the beginning of the large fourth helix correspond between the two structures; 
the topology of these elements is identical in both structures. However, no N-terminal helix is 
observed for C3a in the crystal, whereas a well-defined, well-docked helix is seen for C5a in 
solution. A well-ordered C-terminal fragment is observed for C3a in the crystal, whereas the 
conformation of C5a in solution is disordered in that region. Are the observed differences due to 
the difference in species, to the difference in conditions, or to both? This puzzle was (partially) 
solved by the determination of the secondary structure of C3a in solution [16]. We found that the 
C-terminus of C3a in solution is also disordered, just like that of C5a. Apparently, intermolecular 
contacts in the crystal stabilize a helical conformation for this region. The NMR data for C3a in 
solution also indicate that C3a, like C5a, has a helix at its N-terminus. However, the data indicate 
that this helix is less stable than its C5a counterpart (fraying towards the N-terminal side) and 
that the docking of this helix against the core of the molecule is unstable as well. Nevertheless, the 
helix exists in solution. It thus turns out that the differences observed between the crystal struc- 
ture for C3a and the solution structure for C5a are mainly due to differences in conditions. 
Once the structure was determined, functional information that was acquired over the years 
could be put in context. It was determined that a synthetic octapeptide corresponding to the last 
eight residues of C5a is active in receptor binding [17]. It was therefore very disappointing to find 
that the C-terminal part of C5a is unstructured in solution; no structural template for pep- 
tidomimetics could thus be generated. The NMR information did suggest that there was no 
particular reason to try to make peptides of a particular secondary structure. The NMR-derived 
noninformation in this region is also of relevance to drug design for C3a. Peptides corresponding 
to the C-terminal region of C3a account for 100% of the activity of the molecule and efforts have 
been directed to improvement of the models of these peptides by conformational restriction [18]. 
The NMR data clearly caution against the uncritical use of crystal coordinates for structural 
modeling of these peptides. 
The C-terminus accounts for only part of the activity of C5a, since synthetic peptides based on 
the natural sequence have 10 .4 M receptor-binding affinity while the affinity of C5a for the same 
receptor is in the subnanomolar range. It is remarkable, however, that these peptides are full 
agonists. Genetically constructed truncated C5a molecules comprising residues 1-62 (the 'core') 
also showed residual receptor binding and full agonism at 10 -s M. It therefore seems that the 
C-terminal part and the core of the molecule are both required for full affinity [19]. This is 
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Fig. 5. Molscript [69] drawing of C5a in solution. Several residues of interest, as discussed in the text, are indicated. The 
conformation of the extended C-terminal part was chosen arbitrarily. The darker shading in the interface region between 
the first two helices corresponds to the area displaying large chemical-shift changes for the mutant Ala26-->Met (Fig. 6). 
corroborated by results of  mutagenesis and chemical modification. Step-by-step hydrolysis of  the 
N-terminus of  C5a resulted in a progressive loss of  activity and mutations Ala26~Met and 
Arg4°-->Gly in the 'core' gave rise to a 10-fold loss in activity [19]. Inspection of  the 3D structure 
of C5a shows that these 'hot spots' are spread over the entire molecule (Fig. 5) and that they are 
not  adjacent to the C-terminus at all. In order to help understand these results, we used N M R  to 
study some of  the mutants. Mutants that did not show a change in activity were found to be 
structurally equivalent to wild-type C5a, as the 2D NOESY data for these molecules superim- 
posed. Almost complete superimposition of  NOESY spectra of  wild-type and mutant Arg4°-->Gly 
was also possible; however, minor structural perturbations were seen for the backbone of  residue 
40 itself and for its direct neighbors. Therefore, the loss of  affinity in this mutant must indicate 
that Arg 4°, or at the very least its direct surroundings, are involved in receptor binding. As 
expected, Arg 4° is a surface residue. The mutant  Ala26-~Met is very different. Ala 26 is found on the 
interface between the first and second helix and is buried (Fig. 5). How can mutagenesis here 
cause activity loss? The answer is that more global conformational changes are induced by this 
amino acid change. Careful N M R  studies indicated that the chemical shifts of residues in the 
entire interface between the first two helices were disturbed (Fig. 6), suggestive of  extensive 
change in this area (indicated as darkened area in Fig. 5). The largest shift changes were found in 
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Fig. 6. The changes in chemical shift for H ~ and H N in the C5a mutant Ala"6-4Met. 
no other areas of significant shift changes were found; importantiy, both regions already implied 
in activity, the C-terminus and the Arg 4° area, do not show any changes in NMR parameters. A 
key NOE defining the docking of the first helix to the remainder of the molecule, the NOE 
Alal°-Tyr 23 (residues shown in Fig. 5), was absent from the NOESY spectrum of the mutant. 
Taken together, these data strongly suggest that the docking of the first helix is affected and that 
possibly the helix has come loose in a time-shared manner. It is interesting that residue 26 in C3a 
is also a methionine and that the first helix in C3a seems loose as welt. The combination of N M R  
data and mutagenesis thus showed that in addition to the C-terminus, Arg 4° and the N-terminus 
are important for receptor binding. Mutagenesis of solvent-exposed residues in the first helix, 
however, did not affect activity. It therefore appears that not the helix itself, but rather the loop 
region between the first two helices is involved and that the second receptor binding site in C5a 
is very extended and that it is noncontiguous. It is located at the top of the molecule in the view 
of Fig. 5. It must be emphasized that the identification of the turn region between the first two 
helices is based on what seems a dynamic rather than a static change in structure. It is interesting 
to speculate that this secondary site mimics the C-terminal site (or vice versa). It was found that 
the C-terminal residue Arg TM is extremely important for activity in peptides derived from that 
area. It is thus possibly not coincidental that an arginine residue (Arg 4°) is part of the 'top' site. 
We have obtained some preliminary mutagenesis data, showing that other residues in the top of 
the molecule are relevant for receptor binding, thus corroborating the notion of a secondary 
binding site at this location. 
This information on the secondary site suggests the following strategy for drug design: potential 
drugs should be based on a scaffolding of extended structure to span the distance from Arg 4° to 
the turn between the first two helices, while the functional groups on this framework can be derived 
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from those found to be optimal in the C-terminus-derived peptides. The NMR work showed that 
the C-terminus of C5a is not well ordered in solution. One should study a peptide corresponding 
to this region when bound to the C5a receptor, using techniques such as transferred NOE or 
isotope editing (described below) to obtain useful information about this portion of the molecule. 
In addition to information directly useful for the drug design process, the combined NMR and 
mutagenesis studies on C5a and C3a revealed that (i) solution and crystal structures can be 
different, sometimes in extremely important areas; (ii) mutagenesis of internal residues can give 
rise to widespread conformational changes that compound difficulties in interpretation of the 
biological consequences of these mutations; and (iii) these changes can be as subtle as changes in 
a conformational equilibrium in solution. 
THE NMR STUDY OF THE STROMELYSIN CATALYTIC DOMAIN 
Background 
Human stromelysin belongs to a family of matrix metalloproteinases involved in the remodel- 
ing of the extracellular matrix. Stromelysin is a wide-spectrum zinc endoproteinase of MW 52 
kDa that hydrolyzes collagens, gelatins, fibronectin, laminin and several cartilage proteoglycans. 
Stromelysin can participate in its own activation and in that of other matrix metaltoproteinases 
such as collagenases and gelatinases (for reviews see References 20 and 21). It appears that 
elevated levels of matrix metalloproteinases in general and stromelysins in particular are associat- 
ed with tumor metastasis and invasion, caused by degradation of the extracellular matrix [2 t-28]. 
Enhanced activity of stromelysin was also observed in tissues afflicted by rheumatoid arthritis 
[29] and osteoarthritis [30]. Stromelysin and the family of matrix metalloproteinase proteins as a 
whole are therefore important targets for antimetastasis and arthritis drug research. 
No 3D structures are known for any of the matrix metalloproteinases to date, nor for any other 
protein that shares significant overall amino acid homology with these molecules. With its molecu- 
lar weight of 52 kDa, stromelysin is beyond the current limits of NMR methodology for detailed 
studies. However, strong evidence supports the hypothesis that the N-terminal 19.5-kDa domain 
of the mature protein (Phe83-Pro 256) is necessary and sufficient for stromelysin catalytic activity 
[31-34]. 
The size of the stromelysin catalytic domain is within the limits of the new multidimensional 
multinuclear NMR methods. We describe here some aspects of the resonance assignment work 
currently being carried out. The ultimate goal is to determine the 3D structure in solution to help 
understand the architecture, catalytic mechanism, specificity, activation and in vitro inhibition of 
stromelysin. This knowledge will then be utilized to help in the design of synthetic inhibitors 
specific for this protein. 
3D NMR of stromelysin 
For molecules larger than 10 kDa, analysis of the structure with proton NMR as described for 
C5a becomes impossible. The reasons are threefold [35]: (i) Larger molecules display more 
resonances and therefore create spectral overlap problems. This point is already appreciated 
when inspecting the NOESY spectrum of C5a (Fig. 3): not much space is left for more cross 
peaks. (ii) With larger molecules, relaxation becomes more effective. The larger linewidths associ- 
ated with this enhanced relaxation compound the overlap problem. (iii) Proton coherence transfer 
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Fig. 7. Simplified pulse sequences for the four 3D NMR experiments discussed in the text. Black boxes show time 
demarcations; the bold lines indicate the flow of coherence. The coherence residences t 1, t 2 and t3 are also shown for the 
peptide fragments on the right. The hatched box in the HCCH experiment indicates coherence transfer by HOHAHA 
methods. 
is slow as compared to the fast relaxation and becomes inefficient; for these molecules, experi- 
ments such as COSY display unacceptable low sensitivity. 
The first problem is (partially) overcome by increasing the dimensionality of the experiments. 
It would seem that 3D proton experiments as discussed above would be good candidates to solve 
the problem. This is not the case, because such experiments are dependent on coherence transfer 
over 1H-IH scalar couplings and will fail, except for extraordinary cases, on the basis of the third 
problem. The key development that enabled application of modern multidimensional NMR is the 
use of heteronuclear NMR techniques. Heteronuclear scalar couplings are generally large, there- 
by allowing efficient coherence transfer and thus allowing the construction of multidimensional 
experiments. A problem is that the naturally abundant carbon nucleus, 12C, does not have a 
magnetic moment and that the naturally most abundant nitrogen isotope, 14N, has spin 1 and 
displays very broad resonance lines. These nuclei need to be replaced by the stable isotopes 13C 
and 15N, which are both high-resolution NMR nuclei. For proteins this can be accomplished 
relatively easily by expressing the cloned protein in E. eoli, growing on a medium containing 
15NH4C1 and glucose I3C 6. 
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Fig. 8. Stereodiagram of the 3D ~SN-resolved NOESY-HSQC spectrum of the strometysin catalytic domain. The width 
and height of the box represent proton dimensions; the depth is the ~SN-dimension. 
The first heteronuclear 3D NMR experiment [36] was the 3D 15N-resolved NOESY experi- 
ment. Even though it was carried out on a labeled tripeptide, it was recognized that the experi- 
ment is the key to the analysis of larger molecules by NMR. The principle of the 3D lSN-resolved 
NOESY spectrum is straightforward when referring to Fig. 7, where we have drawn simplified 
representations of several key heteronuclear 3D NMR experiments. We trace the coherence path 
ofa  do~N(i,i + 1) NOE, an NOE between the H a of residue i and the H N of residue i + 1, in the 3D 
NOESY-HSQC (HSQC means Heteronuclear Single Quantum Correlation) experiment (Fig. 
7A). Coherence starts on the H ~ (tl), and is transferred by NOE to the H~(i + 1). Before the 
frequency of the H N is measured, the coherence is transferred to the attached 15N nucleus, the 
frequency of which is sampled (t2). The coherence is then brought back to the H TM where its 
frequency is finally measured (t3). This rather complicated pathway is followed for reasons of 
sensitivity. A similar path is followed by the NOE between the H a and its own HN; coherence 
starting on H~(i + 1) will be transferred to HN(i + 1) as welt. As a result, all protons reporting by 
NOE to a specific H TM will be labeled with the amide nitrogen frequency of that amide proton. One 
thus obtains all these NOEs on a 'skewer' at frequency coordinates (f2,f3) = (lSN,HN) in 3D space. 
An ensemble of skewers is seen on a particular plane with a particular 15N frequency. The 
experiment is extremely powerful and works well on even the largest molecules. The reason is that 
the 15N-HN scalar coupling is very large (90 Hz) so that coherence can be quickly transferred 
without much relaxation loss. The 15N resonances themselves are very narrow (around 8 Hz for 
proteins of 20 kDa) and relaxation is limited when the I5N frequency is sampled. As a result, the 
15N-resolved NOESY-HSQC experiment has a sensitivity close to that of the parent NOESY 
experiment for proteins up to 20 kDa [36-38]. Figure 8 shows a stereoptot of the 3D NOESY- 
HSQC experiment as carried out for the stromelysin catalytic domain. Data in such spectra are 
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Fig. 9, The alignment of the ~H-amide 'skewers' at the corresponding ~SN frequency from the 3D ~SN-resolved NOESY- 
HSQC spectrum. The data were collected with a 1,5-mM sample of 15N-labeled stromelysin catalytic domain. The 
sequential alignment of the residues forming the active-site helix (residues Leu ~95 through Leu 2°9) is shown. Sequential 
dNN(i,i + 1) and dc~N(i,i + 1) NOEs are indicated with thin lines. 
analyzed by taking 2D cross sections perpendicular to the 15N axis. The resulting planes look like 
1H-1H NOESY spectra of small molecules and are virtually devoid of overlap. However, skewers 
belonging to adjacent residues will generally not tie in the same plane. The entire 3D matrix must 
thus be scanned for corresponding skewers. Corresponding skewers can be 'pasted' on a single 
plane and compared on the computer screen [39]. A plot of a sequence of adjacent skewers is 
shown in Fig. 9. The NOEs dNN(i,i + 1) and dotN(i,i + 1) as drawn confirm that these skewers 
indeed belong to amino acid residues adjacent in sequence. 
A similar 3D 15N 'editing', 'resolving' or 'separating' technique can be applied to through-bond 
XH-IH correlation (HOHAHA) experiments [35,39]. Thus in a HOHAHA spectrum, skewers in 
3D space contain the more-or-less complete spin systems of the amino acid residues. A combined 
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analysis of NOESY-HSQC and HOHAHA-HSQC will yield the sequential assignment: spin- 
system identification cross peaks obtained from HOHAHA-HSQC are aligned per corresponding 
skewer to identify the intraresidue cross peaks in NOESY-HSQC. The remaining cross peaks in 
the NOE skewers contain the sequential cross peaks from which the assignment can be obtained. 
This (semiconventional) method of combined analysis works well only for some larger proteins 
which have exceptionally small linewidths and contain much [~-structure (because of sensitivity 
limitations of the HOHAHA experiment itself). For stromelysin, the HOHAHA-HSQC experi- 
ment turned out to be of insufficient sensitivity for practical use. 
Structure determination of larger proteins using 13C-resolved 3D and 4D NMR 
Before describing the relatively involved alternative methods for the assignment of the reso- 
nances of larger proteins such as stromelysin, we want to sketch the entire process of structure 
determination of larger molecules. Assuming that resonance assignments can be obtained, one 
wants to proceed by identifying NOEs for structure calculation. Many of these NOEs will come 
from side-chain-side-chain interactions that resonate in the most crowded part of the 2D NOESY 
spectrum (see Fig. 10A). 15N-editing will not help here, since the protons are not 15N-bound. By 
labeling the molecule with 13C, the NOESY data can be pulled apart with respect to the 13C 
chemical shifts (Fig. 10B). Considerable simplification is achieved in a fashion completely analo- 
gous to that described for 15N-resolved NOESY spectra [40]. However, it was found that the 
resolution is still insufficient in three dimensions and the experiment was therefore extended to a 
4D doubly ~3C-resolved NOESY experiment [41-431. It was found that the 4D NOESY spectrum 
is essential for structure determination of larger proteins. The consequence is that the 13C reso- 
nances have to be assigned as well. Once that process is completed, structure determination can 
proceed on the basis of the identified NOEs as previously described (distance geometry/molecular 
dynamics/simulated annealing [11-15]). 
Through-bond main-chain-directed assignments for stromelysin 
These methods are referred to as triple-resonance assignment methods and can only be carried 
out for proteins that are uniformly and 100% labeled in 13C and 15N. The majority of these new 
techniques were pioneered and developed in the laboratory of Bax [44]. The objective in triple- 
resonance experiments is to transfer magnetization over the backbone atoms and to measure the 
frequency of the nuclei involved in the transfer. Coherence transfer from nucleus A to nucleus B 
is achieved by COSY-type mechanisms involving heteronuclear scalar couplings. Most triple- 
resonance experiments involve the HN unit from the peptide linkage as anchor. In the HNCA 
experiment (Reference 45, Fig. 7B), coherence starts at the amide proton and is transferred to the 
15N nucleus, where the frequency is sampled (t 0. The coherence is further transferred to the C a 
nucleus and that frequency is sampled. The coherence is now pulsed back over the same pathway 
to the same amide proton for which the FID is detected (t3). The experiment is carried out in this 
complicated way for reasons of sensitivity, related with magnitudes of the scalar couplings, the 
relaxation characteristics of the different nuclei involved and exploitation of Boltzmann polariza- 
tion transfer. After 3D Fourier transformation one obtains one 3D cross peak for every amino 
acid residue (except proline) whose three frequency coordinates are the amide nitrogen, the 
c~-carbon and amide proton in f~, f2 and f3, respectively. In the related 3D HN(CO)CA experiment 
(Reference 46, Fig. 7C) (which takes the coherence in a different direction and uses one additional 
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Fig. 10. The 3D ~3C-resolved HSQC-NOESY experiment of a sample of 13C-labded T4-1ysozyme (19.5 kDa). (A) A 
projection of the data. (B) A IH-1H plane through the data showing the achieved simplification. 
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step), the frequency coordinates are the amide nitrogen of residue i, the c~-carbon of residue i - 1 
and the amide proton of residue i in I"1, t"2 and f3, respectively. 
Accordingly, the 2D H ~ shift-correlation map is correlated with the C a chemical shifts of the 
same and the previous amino acid residues in the 3D HNCA and HN(CO)CA experiments, 
respectively. Thus, theoretically, all H, N and C ~ resonances in the protein can be interconnected 
with these two experiments and be assigned. In practice, however, this is not possible due to 
overlap in the chemical shifts of the C ~ resonances. In fact, the linkage from amino acid to amino 
acid is only a 1D connection and much overlap occurs. Therefore, additional pathways need to 
be exploited as well. A combination of 3D HN(CA)HA [47] and HA(CACO)NH [48] worked well 
for stromelysin tO give another 1D linkage between the amino acids but now over H a. Thus, for 
a given amino acid linkage, as long as both H a and C a are not simultaneously degenerate with 
another H '~ and C ~ pair, the connectivity can be derived from the four experiments in conjunction. 
Figure 11 shows a double 3D connectivity path using the two pairs of 3D experiments described 
above for the stromelysin catalytic domain. For every peptide linkage a computer search routine 
identified a C~-(CO)-HN-C a 'tee' formed from the 3D HNCA and HN(CO)CA experiments as 
shown in the upper row, or an H~(C~CO)HN(Ca)H a tee from 3D HN(CA)HA and 
HA(CACO)NH as shown in the lower row. The tees are connected with corresponding C ~ 
resonances for the top row and corresponding H a resonances for the bottom row. The require- 
ment is, of course, that both pathways delineate the same amino acid connections as indicated. 
The connectivity pathways generally do not reach from one side of the protein to the other, 
because of locally unfavorable relaxation conditions and/or breaks due to the presence of proline 
residues. Therefore, a method is needed to establish the positions of the fragments in the protein. 
A particularly elegant way is found by using residue-specific labeling [49]. For stromelysin, we 
have used the protein with only phenylalanine, alanine or leucine 15N-labeled. Proton-15N chem- 
ical-shift correlation maps of these constructs thus gave the coordinates of the ~SN-1H shifts for 
these residues. Subsequently this information is used to assign amino acid type identification to 
two of the three dimensions of some of the cross peaks of the triple-resonance experiments. Using 
this very limited information, all triple-resonance-connected peptide fragments could be placed in 
the sequence [501. 
NMR assignments can already help in understanding protein structure: Possibilities for large 
proteins 
The NMR (main-chain) assignment procedure is an integral part of a full structure determina- 
tion process. Nevertheless, the obtained assignments can already be used to aid in the understand- 
ing of the protein structure and function before the structure determination is complete. First, it 
is only a small step to scan for the secondary-structure NOEs once all H a and H N protons have 
been assigned [5]. For larger proteins the process is essentially the same as that illustrated for C5a. 
The availability of experimentally determined secondary structure is of great importance for 
homology modeling and for theoretical protein-structure calculations: the positions of deletions 
and insertions, generally between the elements of secondary structure, will become apparent, 
helping in the alignment of homologous structures. The availability of the secondary structure 
may also reveal homology previously gone undetected, thus allowing modeling efforts to start 
early [50]. Secondly, the assigned spectra may function as a monitor for structural alterations 
upon mutagenesis of chemical modifications; generally one will use the 15N-1H correlation map 
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Fig. 11. Alignment of the results from the 3D HNCA, HN(CO)CA, HN(CA)HA and HA(CACO)NH experiments for the 
assignment of several of the main-chain resonances of the stromelysin catalytic domain. In the upper half of the figure 
alternating (~H,13C~) planes of HNCA and HN(CO)CA spectra at particular 15N frequencies are shown as exemplified for 
Ala 112. The ~SN planes and the H N shift ranges were taken at the frequencies corresponding to the residues shown at the 
top of the figure. The HNCA/HN(CO)CA pairs identify the transpeptide C~(i - 1)N(i)H(i)C~'(i)tees. The tees are connected 
sequentially as indicated. The lower half of the figure shows a similar construction for the H=(i - 1)N(i)H(i)H~(i) tees and 
their connections. 
for these purposes. These maps can also be used to monitor intermolecular interactions, i.e., shift 
changes in resonances upon binding of ligands can be used to suggest locations of the interface of 
interaction. Finally, the availability of assignments is sufficient to obtain dynamic information 
from heteronuclear relaxation measurements [51] and interpret the results on a structural level 
when a structural model can be postulated. 
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All of the above uses of main-chain assignments also apply to very large systems for which full 
structure determination may not (yet) be possible because of problems in obtaining side-chain 
assignments (see next paragraph). Three-dimensional models on the basis of secondary structure 
may suggest spatial proximities between residues that could be tested using specific isotopic 
labels. An interactive process between modeling and experimentation can develop in this way. 
Modern NMR spectroscopy can thus help in understanding the structure and function of these 
large molecules. Modeling based on the obtained results will then possibly contribute to drug 
design processes. 
Three-dimensional structure determination of larger proteins: Side-chain assignments 
As argued above for the case of C5a, side-chain assignments are necessary for experimental 
structure determination of any detail. Again, heteronuclear NMR methods are used for this 
process. The one-bond couplings between 13C nuclei are between 34 and 55 Hz. 13C lines are 
approximately 20-30 Hz wide for proteins in the 20 kDa range. This means that through-bond 
information, necessary for the side-chain assignments, can be moved over the 13C-13C bonds. 
These so-called HCCH experiments (Fig. 7D) are carried out [52-54] by starting magnetization 
on e.g. a 1HV nucleus and measuring its frequency (tl), then transferring it to the attached ~3CV and 
measuring its frequency (t2). From there, the coherence is pushed by t3C-13C transfer (HOHA- 
HA) over the ~3C side-chain skeleton to e.g. ~3C% At the end of the trip the coherence is trans- 
ferred out to the attached H a proton where the FID is measured (t3). As a result, one obtains 
1H-IH transfer edited by 13C frequencies. The experiment serves three purposes: (i) it makes 
through-bond correlation possible; (ii) resolution is obtained because the experiment is carried 
out in three or four dimensions; and (iii) spin-system assignments are obtained for the side-chain 
proton and ~3C resonances simultaneously. It is relatively straightforward to interpret the HCCH 
data after the assignment of the main-chain resonances. Note that we have reversed the order of 
proceeding in assignment here: in the conventional 2D or semiconventional ~SN-resolved 3D 
methods, one starts with side-chain identifications and ends with linking them up using NOEs; 
here we first link the main chain and then connect up the side chains. New developments in this 
area focus on the integration of main-chain and side-chain assignments. In principle, magnetiza- 
tion may start on the peripheral protons of the side chain, transferred to the carbon frame of the 
side chain, transferred to the C ~ resonance by 13C-13C COSY-like transfer, followed by transfer 
to the other main-chain atoms. Most new experiments correlate the side-chain carbon or proton 
chemical shifts or both of residue i with the amide ~SN/~H pair of residue i + 1 [55,56]. 
Once side-chain resonance assignments have been obtained, 3D structure determination pro- 
ceeds by identifying the NOE cross peaks in 3D and 4D 13C-resolved NOESY spectra. The 
obtained distance restraints are used in the structure-determination programs as usual. Using 
these methods, several interesting structures and complexes of larger molecules have been deter- 
mined: calmodulin [57], interleukin 113 [58] and the complex of cyclosporin A/cyclophilin [59]. 
From there, the path to drug design will follow the same lines as described for C5a; first, 
biological data will be placed into a structural context. Mutagenesis experiments can be suggested 
and monitored by NMR. For instance, with stromelysin we anticipate being able to identify and 
place in 3D space the essential active-site residues. On this basis, a lead inhibitor can be suggested 
and its complex with the protein studied, after which one hopes to enter an iterative cycle of 
structure determination and drug improvement. 
411 
PROBLEMS WITH NMR OF SMALL LIGANDS 
It is clear from the descriptions above that NMR analysis of larger proteins becomes much 
more involved than the analysis of smaller proteins. One would thus assume that conformational 
analysis, and interactive drug design, must be very easy for small ligands such as (unrestrained) 
peptides. It turns out, however, that this is not true at all: although the techniques involved are 
relatively simple (1H-1H COSY-type experiments and NOESY or ROESY experiments work 
well), the interpretation of the conformational data is not. The problem is that small, nonglobular 
molecules are often in dynamical equilibrium between different conformations. An example was 
described above for the C-terminal peptide of C5a; simultaneous appearance of daN and dNN 
NOEs is not compatible with a single structure. Currently, it is possible to characterize the 
dynamic state better by measuring many heteronuclear three-bond couplings [60] in a labeled 
version of the peptide, allowing the formulation of a dynamic model compatible with scalar and 
NOE information. But even if one would have determined this equilibrium, necessarily involving 
very small free-energy differences between the substates, one would not know which substate 
would be relevant to receptor binding. In principle one never knows this: it is not very likely that 
one will recognize the presence of a minor conformation (say 10%) in an ensemble from the NMR 
data, especially when that conformation is in rapid dynamic equilibrium with the main conforma- 
tion. However, the free-energy difference of 1.4 kcal/mol between these states may be easily 
overcome by the free energy of binding; the bound state is then different from the perceived state 
in solution. Even the NMR analysis of constrained molecules may lead to wrong conclusions as 
was shown by Fesik et al. [61] in their studies of cyclosporin A. 
Clearly, the only way of knowing the conformation of a small ligand when bound to a larger 
molecule is to determine its structure when it is in that state. Now the small-molecule NMR  
becomes a large-molecule NMR problem again. A straightforward way is to determine the 
structure of the entire complex, but the size of most of these complexes is beyond the upper limits 
of even modern NMR methods. In the following sections, the two different approaches that cope 
with these problems, transferred NOE and isotope editing, will be discussed. 
Transferred N OE 
The transferred NOE techniques have been analyzed and popularized mainly by Clore and 
Gronenborn [62,63]. The transferred NOE occurs in equilibrium mixtures where a small ligand is 
in excess over a larger molecule. As an example, we describe a study of the binding of an 
a2-adrenergic receptor-derived peptide to Go-protein (Neubig and Zuiderweg, unpublished 
results). The peptide, named 'Q', is modeled after the carboxy-terminal portion of the putative 
third cytoplasmic loop of the receptor. This region of the receptor is involved in coupling to the 
Go-protein. Free in solution, the peptide shows hardly any NOE intensities (Fig. 12), indicating 
the lack of spatial proximities in the peptide, an NOE-ineffective correlation time, or both. When 
only 2% Go-protein is present, clear NOEs are observed between the different residues of the 
peptide spectrum (Fig. 12). The explanation for the results is that NOEs build up between 
spatially close protons in the peptide when the peptide is transiently bound to the G-protein. 
When the exchange kinetics is faster than the disappearance of the NOE by relaxation processes 
in the free state, NOEs will build up according to the proximities in the bound conformation every 
time the peptide binds. NOEs will also build up according to the proximities in the free conforma- 
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Fig. 12. Transferred NOE spectra of the Q-peptide of the c~-adrenergic receptor. Left: Q-peptide alone. Right: Q-peptide 
in exchange with Go-protein. 
tion every time the peptide is free. The resulting NOE is thus a time-average between bound and 
free states. Since the free state does not display much NOE by itself, the observed NOEs must be 
due to proximities in the bound state, even though this occurs only 2% of the time. The elegance 
of the transferred-NOE experiment is that information on the bound state can be obtained from 
a relatively easily analyzed NMR spectrum that is closely related to the free-state spectrum. The 
spectrum will generally be a fast-exchange chemical-shift average between free and bound shifts 
(but it can also be slow exchange on the chemical-shift scale as long as the exchange rates are 
faster than the relaxation). An additional advantage of the transferred-NOE method is that only 
relatively small quantities of the receptor are needed. However, a major problem with the trans- 
ferred-NOE experiment is related to this very same advantage: the excess peptide may bind 
nonspecifically to many low-affinity sites on the receptor and the observed transferred NOEs may 
thus very well reflect these nonspecifically bound states. It is thus of extreme importance to carry 
out the proper control experiments to rule out such occurrences. A good literature example is that 
given by Behling et al. [64], who studied the conformation of acetylcholine when bound to the 
nicotinic receptor using transferred NOE. These authors had at their disposal 0~-bungarotoxin, 
which is known to compete for the same binding site on the receptor as acetylchotine. Upon 
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addition of the a-bungarotoxin to the sample containing the acetylcholine-receptor mixture, the 
transferred NOEs disappeared, proving that they were due to proximities in the specific interac- 
tion state. We are currently in the process of identifying such controls for the Q-peptide G- 
protein. Irrespective of the nature of the binding in our example, the data in Fig. 12 clearly show 
strong daN and negligible to weak dNN connections, suggesting that the peptide is in an extend- 
ed conformation in this binding mode. 
Isotope editing 
Another approach that studies more directly the bound conformation involves the use of 
isotopes. Much of this approach has been developed in the laboratory of Fesik [65]. In the very 
early days of NMR, isotope editing was already carried out by, for instance, using 13C- or 
19F-labeled ligands and observing shift and/or relaxation changes of these nuclei upon binding. 
Nowadays, one is generally not content with only shift information; in order to obtain conforma- 
tional information on the bound state, one wants to detect 1H-IH NOEs between ligand protons 
in the bound state, and possibly also between protons of the ligand and the receptor in order to 
characterize the interface between the molecules. 
A straightforward but expensive way to obtain such information is to fully deuterate the larger 
molecule; the only proton signals remaining are those from the bound ligand and NOESY spectra 
of the ligand only can be obtained. This method was carried out to study mellitin when bound to 
perdeuterated calmodulin [66]. The advantage of this technique is that simple proton NMR 
methods can be used. Thus, NOESY structure determination of the bound ligand can be per- 
formed. The obtained information may be very valuable for drug design purposes, as the ligand 
is studied in its relevant state. The disadvantage of the perdeuteration approach is that simple 
proton NMR methods must be used. The powerful heteronuclear 3D and 4D methods are 
excluded and severe restrictions exist on the size of molecules that can be handled. The other 
drawback is that it is difficult to generate large quantities of perdeuterated proteins, since growth 
of E. coli in the toxic D20 medium is generally quite modest. 
A second approach using deuterium for isotopic editing involves labeling of the ligand. Two 
experiments are recorded: (i) a NOESY experiment using a normal, proton-labeled ligand bound 
to a normal, proton-labeled receptor and (ii) a NOESY experiment using deuterated ligand, also 
bound to its proton-labeled receptor [67]. The 2D spectra are subtracted and the difference 
spectrum shows only NOEs between ligand protons and between ligand protons and receptor 
protons. Again, structural information about the relevant bound state is obtained. In addition, 
NOEs between ligand and receptor are identified, showing which ligand groups are directly 
involved in binding. This information is obviously invaluable for drug design processes, even 
when the receptor groups involved in this process cannot be identified (easily). The deuterated- 
ligand approach has the same advantage/disadvantage as the deuterated-receptor approach 
described above, in that proton NMR can and must be used, therefore limiting the application to 
smaller complexes only. Nevertheless, quite useful information could be obtained for the bound 
state of a peptidic inhibitor bound to pepsin [67]. A possible advantage over the perdeuterated- 
macromolecule approach is that it is relatively easy to prepare the deuterated ligand if it is a 
natural peptide (using solid-state synthesis with deuterated amino acids). 
The third and most powerful use of isotopes is isotope-edited NMR using 15N- and/or 13C- 
labeled ligand. This method was actually a predecessor of the heteronuclear 3D experiments. 
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13 Fig. 13. t3C-edited NOESY spectrum of 9,10 C-labeled cyclosporin A bound to unlabeled cyclophilin [56]. The data were 
obtained using a sample kindly provided by Dr. S.W. Fesik (Abbott Laboratories). 
Basically, the same technique as the NOESY-HSQC experiment can be used to edit or filter the 
~H subspectrum of an isotopically labeled ligand out of the ~H spectrum of the complex. In this 
method one alternates the phase of the r.f. pulses, affecting the heteronuclei on every other scan 
[65,68]. Protons bound to these heteronuctei through one-bond scalar coupling will sense these 
phase alterations and can be specifically detected by difference spectroscopy since signals of 
protons bound to nuclei not affected by these pulses are subtracted out. An example is shown in 
Fig. 13, where the proton NMR spectrum of partially 13C-labeled cyclosporin A (CsA) bound to 
cyclophilin was made visible using 13C-isotope edited 2D NOE [61]. This type of isotopic editing 
is very powerful, as it can also be executed as heteronuclear 3D and 4D experiments. Therefore, 
larger systems can be analyzed with these techniques than possible with the perdeuteration 
methods. A very important discovery with respect to the structure of cyclosporin was made with 
the help of the spectrum in Fig. 13, which illustrates the importance of studying bound ligands. 
The crystal structure of CsA [70] as well as the NMR structure of free CsA in solution [70] 
(chloroform) show the presence of a cis peptide bond between residues 9 and 10. In the NMR 
data, this conformation was evidenced by a strong NOE cross peak between the et-protons of 
residues 9 and 10. However, in the NOESY spectrum of CsA bound to cyclophilin (in aqueous 
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solvent) no NOE cross peak is observed between the H ~ protons of these residues, as indicated in 
the figure. This is very strong evidence that this peptide bond is trans in the complex, thus 
contrasting with the conformation as obtained from free CsA in chloroform solution and in the 
crystal. (Recent NMR investigations of a more soluble CsA analog indicate that a trans peptide 
bond may prevail for this related free molecule in solution when dissolved in H20 [71].) 
It is clear that information of this type is indispensable for successful drug design. Fesik's group 
went on to determine the full 3D structure of fully 13C-labeled CsA while bound to cyclophilin, 
using (isotopic-filtered) heteronuclear 3D and 4D methods [59]. The NMR approach for the 
study of this small molecule has here become identical to that used for larger molecules. 
CONCLUSIONS 
NMR spectroscopy of proteins and peptides can aid in the drug design process in several 
different ways. For small proteins (MW < 10 kDa), full 3D structures can be determined with 
relative ease. The 3D structure is used to help understand biochemical and genetic experiments on 
the protein; ultimately the relevant part of the 3D structure can serve as a template for the design 
of drugs. For larger proteins (10 < MW < 30 kDa) the NMR assignment process is more difficult, 
involving many multidimensional NMR experiments using isotopically labeled proteins. Never- 
theless, the structure determination methods are all laid out for this class of molecules and are 
basically not different from those used for the smaller molecules. The drug design process can still 
be based on the full structure and possibly of the complex of the drug and the protein. For even 
larger molecules, NMR studies may not proceed beyond the assignment and secondary-structure 
stage. However, the obtained information may be used to aid in computer modeling procedures, 
to monitor binding studies and to gather dynamic information. Drug design will thus indirectly 
follow from the NMR data through modeling. The conformation of many small peptidic ligands 
is difficult to characterize in solution, because of dynamic averaging processes. Therefore, these 
ligands are best studied when interacting or complexed with the macromolecular receptor. Sever- 
al NMR techniques that were developed to obtain structural information in these heterogeneous 
systems were discussed. Direct valuable information on the conformation of the bound drug can 
be obtained with these methods. 
The presence of dynamic equilibria between different conformations can be detected by NMR, 
although the exact characterization of the states involved is not straightforward. This dynamic 
NMR information shows that the conformation of a protein in a crystal can be biased. It also 
reveals that site-directed mutagenesis can induce subtle conformational changes that are dynamic 
rather than static in nature. 
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